Tumour control probability: a formulation applicable to any temporal protocol of dose delivery

被引:132
|
作者
Zaider, M
Minerbo, GN
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA
[2] Schlumberger Oilfield Serv, Sugar Land, TX 77478 USA
来源
PHYSICS IN MEDICINE AND BIOLOGY | 2000年 / 45卷 / 02期
关键词
D O I
10.1088/0031-9155/45/2/303
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
An analytic expression for the tumour control probability (TCP), valid for any temporal distribution of dose, is discussed. The TCP model, derived using the theory of birth-and-death stochastic processes, generalizes several results previously obtained. The TCP equation is TCP(t) = [ 1- (S(t) e((b-d)t) / (1+bS(t)e((b-d)t) integral 0t dt'/S(t') e((b-d)t'))](n) where S(t) is the survival probability at time t of the n clonogenic tumour cells initially present (at t = 0), and b and d are, respectively, the birth and death rates of these cells. Equivalently, b = 0.693/ T-pot and dib is the cell loss factor of the tumour. In this expression t refers to any time during or after the treatment; typically, one would take for t the end of the treatment period or the expected remaining life span of the patient. This model, which provides a comprehensive framework for predicting TCP, can be used predictively, or-when clinical data are available for one particular treatment modality (e.g. fractionated radiotherapy)-to obtain TCP-equivalent regimens for other modalities (e.g. low dose-rate treatments).
引用
收藏
页码:279 / 293
页数:15
相关论文
共 36 条
  • [21] Relationship between the generalized equivalent uniform dose formulation and the Poisson statistics-based tumor control probability model
    Zhou, SM
    Das, S
    Wang, ZH
    Marks, LB
    MEDICAL PHYSICS, 2004, 31 (09) : 2606 - 2609
  • [22] Metabolic control probability in tumour subvolumes or how to guide tumour dose redistribution in non-small cell lung cancer (NSCLC): An exploratory clinical study
    Petit, Steven F.
    Aerts, Hugo J. W. L.
    van Loon, Judith G. M.
    Offermann, Claudia
    Houben, Ruud
    Winkens, Bjorn
    Ollers, Michel C.
    Lambin, Philippe
    De Ruysscher, Dirk
    Dekker, Andre L. A. J.
    RADIOTHERAPY AND ONCOLOGY, 2009, 91 (03) : 393 - 398
  • [23] On the possible increase in local tumour control probability for gliomas exhibiting low dose hyper-radiosensitivity using a pulsed schedule
    Tome, W. A.
    Howard, S. P.
    BRITISH JOURNAL OF RADIOLOGY, 2007, 80 (949): : 32 - 37
  • [24] Modeling tumour control probability based on dose level subgroups, using clinical outcome data from a large randomized trial
    Witte, M.
    Lebesque, J.
    Geer vd, J.
    Schneider, C.
    Heemsbergen, W.
    van Herk, M.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S133 - S134
  • [25] Comparison of Acuros (AXB) and Anisotropic Analytical Algorithm (AAA) for dose calculation in treatment of oesophageal cancer: effects on modelling tumour control probability
    Sriram Padmanaban
    Samantha Warren
    Anthony Walsh
    Mike Partridge
    Maria A Hawkins
    Radiation Oncology, 9
  • [26] Comparison of Acuros (AXB) and Anisotropic Analytical Algorithm (AAA) for dose calculation in treatment of oesophageal cancer: effects on modelling tumour control probability
    Padmanaban, Sriram
    Warren, Samantha
    Walsh, Anthony
    Partridge, Mike
    Hawkins, Maria A.
    RADIATION ONCOLOGY, 2014, 9
  • [27] Influence of catheters on predicted tumour control probability and severity of acute genitourinary toxicity during high-dose-rate brachytherapy prostate boost
    Tunio, Mutahir
    Hashmi, Altaf
    Rafi, Mansoor
    Mohsin, Rehan
    Zameer, Asad
    JOURNAL OF RADIOTHERAPY IN PRACTICE, 2011, 10 (03) : 173 - 180
  • [28] RADIOTHERAPY 5.0-VOXEL CONTROL PROBABILITY GUIDED RADIOTHERAPY (VCP-GRT): AN ATTEMPT TO INTEGRATE MOLECULAR IMAGING AND DOSE UNCERTAINTIES WITH MODERN RADIATION DOSE DELIVERY
    Lambin, P.
    Petit, S.
    van Elmpt, W.
    Fekkes, S.
    Wouters, B.
    Dekker, A.
    De Ruysscher, D.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S300 - S301
  • [29] Do selective radiation dose escalation and tumour hypoxia status impact the loco-regional tumour control after radio-chemotherapy of head & neck tumours? The ESCALOX protocol
    Pigorsch, Steffi U.
    Wilkens, Jan J.
    Kampfer, Severin
    Kehl, Victoria
    Hapfelmeier, Alexander
    Schlaeger, Christian
    Bier, Henning
    Schwaiger, Markus
    Combs, Stephanie E.
    RADIATION ONCOLOGY, 2017, 12
  • [30] Do selective radiation dose escalation and tumour hypoxia status impact the loco-regional tumour control after radio-chemotherapy of head & neck tumours? The ESCALOX protocol
    Steffi U. Pigorsch
    Jan J. Wilkens
    Severin Kampfer
    Victoria Kehl
    Alexander Hapfelmeier
    Christian Schläger
    Henning Bier
    Markus Schwaiger
    Stephanie E. Combs
    Radiation Oncology, 12